NLRX1 and cranioectodermal dysplasia: NLRX1 and NLRP12 are negative regulators of inflammation that impact a variety of inflammatory pathways and have been implicated in several diseases (26–40) and may be further implicated in patients with gluten sensitivities like CeD and NCGS.